This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm of brain and other parts of central nervous system
CD2_BENIGN_BRAIN_CNS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10-D36
- Name in latin
- Neoplasmata benigna systematis nervosi centralis et nervorum cranialium
Similar endpoints
↥List of similar endpoints to
Benign neoplasm of brain and other parts of central nervous system
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasms
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2479 | 1413 | 1066 |
| Unadjusted period prevalence (%) | 0.48 | 0.48 | 0.47 |
| Median age at first event (years) | 53.69 | 52.19 | 55.68 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2228
- Matched controls
- 22281
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
13.8
323.0
689
699
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
109.0
323.0
507
60
D33.30
ICD-10 Finland
Acoustic neuroma
+∞
323.0
744
*
D33.45
ICD-10 Finland
Benign Schwannom in the nerve root of the spinal cord
+∞
258.4
243
*
H02AB02
ATC
dexamethasone; systemic
41.7
231.0
291
80
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
+∞
229.2
216
*
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
42.5
223.3
280
75
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
202.1
213.3
219
12
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
169.7
193.1
201
13
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
+∞
191.4
181
*
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
1442.4
140.1
135
*
130
Kela drug reimbursment
Malignant tumour
+∞
139.0
132
*
D33.07
ICD-10 Finland
Colloid coast in cerebral ventricle
+∞
130.5
124
*
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
24.4
126.3
182
81
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
13.0
121.8
223
189
WF002
NOMESCO Finland
Radical radiotherapy
171.5
109.3
114
7
C61
ICD-10 Finland
Malignant neoplasm of prostate
290.1
108.9
110
*
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
8.0
108.4
260
361
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
106.1
101
*
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
38.9
103.6
132
36
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.7
101.2
383
944
DFF00
NOMESCO Finland
Pure tone audiometry
4.5
96.6
386
1001
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
+∞
96.5
92
*
D33.02
ICD-10 Finland
Another benign medial tumor of the cerebrum
+∞
92.3
88
*
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
+∞
92.3
88
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.4
90.5
526
1873
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
33.0
90.1
119
38
PJA12
NOMESCO Finland
Sentinel node biopsy
460.6
89.8
89
*
115
Kela drug reimbursment
Breast cancer
+∞
89.1
85
*
AA1AD
NOMESCO Finland
CT of head and brain
2.8
86.5
703
3132
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
85.7
702
3141
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
+∞
84.9
81
*
D33.3
ICD-10 Finland
Benign neoplasm: Cranial nerves
+∞
84.9
81
*
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
18.2
84.8
134
78
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.8
82.9
252
480
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
82.8
79
*
D33.37
ICD-10 Finland
Another benign tumor of the cranial nerves
+∞
81.8
78
*
2251A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cranial nerves
+∞
81.8
78
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
127.7
80.5
86
7
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
+∞
79.6
76
*
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
273.4
78.0
79
*
A04AA02
ATC
granisetron; systemic, transdermal
73.4
74.8
85
12
2152
FHL
Extraction, big brain
196.5
73.6
76
*
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
+∞
72.3
69
*
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
101.0
71.3
78
8
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
9.5
71.3
152
171
D33.43
ICD-10 Finland
Spinal cord
+∞
71.2
68
*
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
65.4
70.9
82
13
9560/0-C72.0
ICD-O-3
Schwannoma, NOS, of spinal cord
+∞
70.2
67
*
D33.4
ICD-10 Finland
Benign neoplasm: Spinal cord
+∞
69.1
66
*
22500
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
+∞
68.1
65
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.0
67.5
441
1668
ZXE20
NOMESCO Finland
More than three and less than five hours
3.2
67.0
393
1379
WF003
NOMESCO Finland
Adjuvant radiotherapy
233.6
66.6
68
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
64.6
64.8
75
12
N03AF02
ATC
oxcarbazepine; oral
6.6
62.4
168
271
XX3DW
NOMESCO Finland
Time consuming IT work
5.1
62.4
209
442
D33.10
ICD-10 Finland
Benign pilosytic astrocytoma of brain stem
+∞
61.7
59
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
59.6
57
*
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
+∞
59.6
57
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
154.0
57.1
60
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
56.5
54
*
116
Kela drug reimbursment
Prostate cancer
+∞
55.4
53
*
2250A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
+∞
54.4
52
*
G91.1
ICD-10 Finland
Obstructive hydrocephalus
29.0
53.8
73
26
D33.14
ICD-10 Finland
Hemangioblastoma and cerebellum
+∞
52.3
50
*
ZXC40
NOMESCO Finland
Use of ultrasound
34.0
50.6
66
20
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
509.0
50.6
50
*
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
26.7
50.5
70
27
N03AX14
ATC
levetiracetam; systemic
7.3
50.4
125
179
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
261.1
50.3
51
*
DFF15
NOMESCO Finland
Speech audiometry
4.7
50.0
181
414
A03FA01
ATC
metoclopramide; systemic, rectal
2.8
49.4
363
1455
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
17.0
49.3
79
48
G51.0
ICD-10 Finland
Bell palsy
6.9
49.2
127
193
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
49.2
472
2203
D33.47
ICD-10 Finland
Other benign neurofibromas in the nerve root of the spinal cord
+∞
49.1
47
*
22510
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Cranial nerves (including optic)
+∞
49.1
47
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
8.4
48.3
109
135
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
2.5
47.8
449
2066
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
8.3
47.1
107
134
AAE32
NOMESCO Finland
Translabyrinthine excision acoustic neurinome
+∞
47.0
45
*
R4110
NOMESCO Finland
Physiotherapy
2.2
46.1
603
3252
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
87.0
46.0
51
6
ZXC95
NOMESCO Finland
Use of surgical navigator
13.9
44.9
78
58
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
44.8
861
5420
9161/1-C71.6
ICD-O-3
Hemangioblastoma of cerebellum, NOS
446.2
44.4
44
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
446.2
44.4
44
*
R51.80
ICD-10 Finland
Headache
2.5
44.3
404
1825
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
7.7
44.0
105
142
H02.2
ICD-10 Finland
Lagophthalmos
63.9
43.3
50
8
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.7
42.2
152
345
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
42.1
790
4901
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
61.2
41.3
48
8
DFF59
NOMESCO Finland
Other assessment of balance
10.3
40.6
81
81
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
12.1
40.1
74
63
HAC20
NOMESCO Finland
Total mastectomy
208.7
40.0
41
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
208.7
40.0
41
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.2
40.0
161
408
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
87.7
38.9
43
5
9560/0-C72.5
ICD-O-3
Schwannoma, NOS, of cranial nerve, NOS
+∞
38.6
37
*
D33.15
ICD-10 Finland
Another benign tumor of the cerebellum
+∞
38.6
37
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
12.4
38.5
70
58
WF099
NOMESCO Finland
Other radiotherapy
43.6
38.2
47
11
L03AA13
ATC
pegfilgrastim; parenteral
383.7
38.1
38
*
N03AF01
ATC
carbamazepine; oral, rectal
3.7
38.0
177
509
ZX050
NOMESCO Finland
Stereotactic radiotherapy
72.8
38.0
43
6
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
27.4
37.3
51
19
WX402
NOMESCO Finland
General anaesthesia
2.4
37.1
352
1608
AAE34
NOMESCO Finland
Other operations on acoustical nerv
373.3
37.1
37
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
373.3
37.1
37
*
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
8.4
36.3
81
99
JN4BD
NOMESCO Finland
Extensive body CT
4.0
36.1
152
401
D33.0
ICD-10 Finland
Benign neoplasm: Brain, supratentorial
362.9
36.1
36
*
G93.0
ICD-10 Finland
Cerebral cysts
25.5
35.9
50
20
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
9.1
35.6
76
86
9560/0-C72.9
ICD-O-3
Schwannoma, NOS, of nervous system, NOS
+∞
35.5
34
*
D33.11
ICD-10 Finland
Brain stem
+∞
35.5
34
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
35.5
34
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
35.5
34
*
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
67.7
35.1
40
6
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
352.5
35.0
35
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
17.8
34.5
54
31
L01AX03
ATC
temozolomide; systemic
+∞
34.5
33
*
D33.41
ICD-10 Finland
Myxopapillary epndymoma of the spinal cord (grade I)
+∞
34.5
33
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
58.1
34.3
40
7
XA800
NOMESCO Finland
Neuropsychological investigation
3.9
34.1
145
386
WF049
NOMESCO Finland
Radiotherapy of metastasis
342.1
34.0
34
*
D43.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal cord
121.9
33.8
36
*
Z3229
NOMESCO Finland
Other healthcare associate professional
2.8
33.7
237
914
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
33.4
32
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.0
33.3
139
364
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
29.9
33.0
44
15
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
6.8
32.8
84
127
L02BA01
ATC
tamoxifen; oral
49.5
32.6
39
8
L01BC06
ATC
capecitabine; oral
+∞
32.4
31
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
32.4
31
*
R42
ICD-10 Finland
Dizziness and giddiness
2.0
32.2
514
2941
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
10.4
31.9
63
62
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
31.9
617
3785
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.4
31.8
120
286
A04AA01
ATC
ondansetron; systemic, rectal
5.2
31.5
100
198
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
31.4
411
2170
C71.60
ICD-10 Finland
Malignant tumor of cerebellum without histology
+∞
31.3
30
*
D33.12
ICD-10 Finland
Cerebellum
+∞
31.3
30
*
XCK00
NOMESCO Finland
Perimetry
2.9
31.2
199
720
N07CA01
ATC
betahistine; oral
2.8
31.1
210
789
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
23.6
30.9
44
19
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
86.3
30.8
34
*
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
111.6
30.7
33
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
8.5
30.3
67
81
D33.46
ICD-10 Finland
Benign neurofibroma in the nerve root of the spinal cord
+∞
30.3
29
*
N02BE01
ATC
paracetamol; systemic, rectal
1.9
30.0
1834
15877
AA1BD
NOMESCO Finland
Extensive CT of head and brain
6.2
29.9
82
136
N76
ICPC
Neoplasm nervous system unspecified
306.3
29.9
30
*
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
5.1
29.8
97
198
2252A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
83.8
29.8
33
*
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
45.7
29.7
36
8
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
+∞
29.2
28
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
29.2
28
*
S18
ICPC
Laceration/cut
1.7
29.2
860
5996
SPAT1153
SPAT
Removal of sutures
1.8
29.2
671
4340
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
40.7
29.0
36
9
N03AX16
ATC
pregabalin; oral
1.9
28.4
519
3100
H93.1
ICD-10 Finland
Tinnitus
2.9
28.2
185
681
L02AE02
ATC
leuprorelin; implant, parenteral
9.7
27.9
57
60
Z3226
NOMESCO Finland
Physiotherapist
2.0
27.9
406
2227
XKD00
NOMESCO Finland
Uroflowmetry
2.2
27.8
299
1440
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
27.1
26
*
WX110
NOMESCO Finland
Local anesthesy
1.6
26.3
1435
11705
TAB00
NOMESCO Finland
Lumbar puncture
3.4
26.1
133
411
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
26.1
25
*
N03AB02
ATC
phenytoin; systemic
7.9
26.0
60
78
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
94.5
25.7
28
*
N75
ICPC
Benign neoplasm nervous system
136.6
25.6
27
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
25.5
848
6051
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
36.0
25.2
32
9
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
25.0
24
*
D33.04
ICD-10 Finland
Temporal lobe
+∞
25.0
24
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
25.0
24
*
Z31.5
ICD-10 Finland
Genetic counselling
3.7
24.9
114
324
C50
ICD-10 Finland
Malignant neoplasm of breast
131.4
24.6
26
*
A02BC02
ATC
pantoprazole; systemic
1.6
24.1
1312
10575
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
10.0
24.0
48
49
N03AX12
ATC
gabapentin; oral
2.0
24.0
353
1933
D33.01
ICD-10 Finland
Medial ganglion glioma of the cerebrum
+∞
24.0
23
*
D33.42
ICD-10 Finland
Hemangioblastoma of the spinal cord
+∞
24.0
23
*
DE2CM
NOMESCO Finland
Acoustic channel extensive MRI examination with 3 Tesla magnet
31.4
23.7
31
10
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
31.4
23.7
31
10
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
8.2
23.7
53
66
WX882
NOMESCO Finland
High dependency care
4.3
23.4
88
210
Y77
ICPC
Malignant neoplasm prostate
+∞
22.9
22
*
D33.03
ICD-10 Finland
Pilosytic lateral astrocytoma of the strobe brain
+∞
22.9
22
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
22.9
22
*
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
+∞
22.9
22
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.2
22.9
72
142
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.2
22.9
243
1159
9530/0-C70.1
ICD-O-3
Meningioma, NOS, of spinal meninges
65.7
22.8
26
*
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
30.4
22.8
30
10
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
7.6
22.6
53
71
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
121.2
22.6
24
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
9.6
22.5
46
49
JN4CD
NOMESCO Finland
Very extensive body CT
5.9
22.4
63
109
Z3231
NOMESCO Finland
Registered nurse
1.7
22.3
550
3581
H02AB09
ATC
hydrocortisone; systemic
4.7
22.1
76
166
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
21.9
21
*
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
+∞
21.9
21
*
9380/3-C71.9
ICD-O-3
Glioma, malignant of brain, NOS
+∞
21.9
21
*
L02BB03
ATC
bicalutamide; oral
+∞
21.9
21
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
21.9
21
*
G91.0
ICD-10 Finland
Communicating hydrocephalus
12.4
21.8
39
32
HA1AA
NOMESCO Finland
X-ray mammography
3.7
21.5
95
263
N02AX02
ATC
tramadol; systemic, rectal
1.6
21.2
840
6189
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
20.9
21.2
31
15
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
21.1
394
2343
H53.2
ICD-10 Finland
Diplopia
3.8
20.9
91
248
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
20.9
20
*
D33.1
ICD-10 Finland
Benign neoplasm: Brain, infratentorial
+∞
20.9
20
*
9391/3-C72.0
ICD-O-3
Ependymoma, NOS, of spinal cord
+∞
20.9
20
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
20.9
20
*
L03AA02
ATC
filgrastim; parenteral
24.4
20.8
29
12
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.2
20.7
65
129
X76
ICPC
Malignant neoplasm breast female
211.8
20.6
21
*
A04AA55
ATC
palonosetron, combinations; systemic
211.8
20.6
21
*
ZXA05
NOMESCO Finland
Left side
1.7
20.4
511
3326
JN4AD
NOMESCO Finland
Body CT examination
3.6
20.1
91
257
101
Kela drug reimbursment
Anterior pituitary hypofunction
9.5
20.1
41
44
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.9
20.1
127
458
E23.00
ICD-10 Finland
Panhypopituitarism
11.4
20.0
37
33
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.8
19.9
135
509
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
19.8
488
3156
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
19.8
19
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
19.8
19
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
19.8
19
*
9394/1-C72.0
ICD-O-3
Myxopapillary ependymoma of spinal cord
+∞
19.8
19
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
19.8
19
*
ZXD05
NOMESCO Finland
Urgent procedure
1.6
19.7
618
4272
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
74.1
19.7
22
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
105.9
19.6
21
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
105.9
19.6
21
*
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.1
19.5
240
1219
H53.4
ICD-10 Finland
Visual field defects
4.1
19.1
75
187
183
Kela drug reimbursment
Lamotrigin and topiramate
7.7
19.1
44
58
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
19.0
224
1118
ZZC00
NOMESCO Finland
Graft of fascia
55.5
18.9
22
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
+∞
18.8
18
*
9421/1-C71.6
ICD-O-3
Pilocytic astrocytoma of cerebellum, NOS
+∞
18.8
18
*
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
+∞
18.8
18
*
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
100.9
18.6
20
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
191.5
18.6
19
*
L02BG04
ATC
letrozole; oral
5.1
18.5
58
115
Z51.5
ICD-10 Finland
Palliative care
4.8
18.4
61
129
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
30.3
18.3
24
8
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
18.3
189
889
N03AX18
ATC
lacosamide; systemic
11.1
18.2
34
31
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
7.9
18.1
41
53
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
11.5
18.0
33
29
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
52.9
18.0
21
*
2259X
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Nervous system, part unspecified
+∞
17.7
17
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
17.7
17
*
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
+∞
17.7
17
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
17.7
17
*
D33
ICD-10 Finland
Benign neoplasm of brain and other parts of central nervous system
+∞
17.7
17
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
17.7
17
*
D43.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system
+∞
17.7
17
*
D33.06
ICD-10 Finland
Plexus papilloma of the ventricle of the brain
+∞
17.7
17
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
17.7
17
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
17.7
17
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.1
17.6
207
1030
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
7.8
17.6
40
52
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
95.8
17.6
19
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.1
17.5
197
962
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
17.4
810
6115
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.8
17.4
114
418
D32.05
ICD-10 Finland
Cerebral meninges
17.1
17.4
27
16
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
42.3
17.3
21
5
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.7
17.0
76
213
N03AG01
ATC
valproic acid; systemic, rectal
2.4
16.9
148
640
G40.10
ICD-10 Finland
Simple partial seizures
9.1
16.9
35
39
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.3
16.8
161
729
A79
ICPC
Malignancy NOS
63.8
16.7
19
*
D32.03
ICD-10 Finland
Benign meningioma in ventricles
63.8
16.7
19
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
16.7
16
*
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
8.9
16.7
35
40
L28
ICPC
Limited function/disability (L)
1.8
16.6
317
1889
2151
FHL
Resection, big brain
171.2
16.5
17
*
H47.2
ICD-10 Finland
Optic atrophy
10.8
16.4
31
29
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
11.7
16.0
29
25
ZZR00
NOMESCO Finland
Flap of skin
9.0
15.9
33
37
AAF00
NOMESCO Finland
Ventriculostomy
8.1
15.8
35
44
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
+∞
15.6
15
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
15.6
15
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
15.6
15
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
15.6
15
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
15.6
15
*
CBH25
NOMESCO Finland
Tarsorrhaphy
85.7
15.6
17
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
85.7
15.6
17
*
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
85.7
15.6
17
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
15.5
287
1690
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
161.0
15.5
16
*
Q85.1
ICD-10 Finland
Tuberous sclerosis
161.0
15.5
16
*
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
3.7
15.5
67
184
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.1
15.3
59
146
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
8.0
15.3
34
43
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
3.1
15.3
85
283
N05BA09
ATC
clobazam; oral
8.8
15.2
32
37
WZC30
NOMESCO Finland
Teaching
2.0
15.1
199
1037
R5120
NOMESCO Finland
Preparation of an aid
3.4
15.1
74
225
N02AA05
ATC
oxycodone; systemic
1.9
14.8
214
1155
2312
FHL
Extirpation or destruction
57.0
14.8
17
*
22520
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
57.0
14.8
17
*
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
2.3
14.7
139
627
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
14.6
14
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
14.6
14
*
9421/1-C71.9
ICD-O-3
Pilocytic astrocytoma of brain, NOS
+∞
14.6
14
*
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
+∞
14.6
14
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
14.6
14
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
14.6
14
*
A04AD12
ATC
aprepitant; systemic
80.6
14.6
16
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
11.9
14.6
26
22
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
14.3
14.5
24
17
UKC02
NOMESCO Finland
Cystoscopy
1.8
14.4
277
1653
NA2DG
NOMESCO Finland
Thoracal spine very extensive MRI examination with high intensity magnet
22.4
14.2
20
9
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
9.8
14.2
28
29
A06AD11
ATC
lactulose; oral
1.8
14.1
263
1551
Z2445
NOMESCO Finland
Psychologist
2.7
14.1
100
388
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
30.2
13.9
18
6
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
17.6
13.8
21
12
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
75.6
13.6
15
*
CBH30
NOMESCO Finland
Tarsorraphy
75.6
13.6
15
*
C72.09
ICD-10 Finland
Malignant tumor of the spinal cord other histology
+∞
13.5
13
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
13.5
13
*
22530
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal cord
+∞
13.5
13
*
C72.00
ICD-10 Finland
Malignant tumor of the spinal cord without histology
+∞
13.5
13
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
13.5
13
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
13.5
13
*
8000/0-C72.4
ICD-O-3
Neoplasm, benign of acoustic nerve
+∞
13.5
13
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
13.5
13
*
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
5.0
13.5
43
88
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
7.2
13.5
32
45
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
34.2
13.5
17
5
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
13.5
153
751
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
140.8
13.5
14
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
140.8
13.5
14
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.7
13.4
91
343
UDC00
NOMESCO Finland
Ear microscopy
2.1
13.4
161
808
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
3.3
13.3
67
209
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
6.1
13.2
35
58
ACB19
NOMESCO Finland
Excision of lesion of peripheral nerve other or unspecified
13.1
12.9
22
17
R13
ICD-10 Finland
Dysphagia
2.2
12.8
129
602
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
10.5
12.7
24
23
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
5.4
12.7
37
69
ZXA00
NOMESCO Finland
Right side
1.5
12.7
498
3575
B01AB05
ATC
enoxaparin; parenteral
1.5
12.6
507
3654
2159
FHL
Other measure in this category
70.2
12.6
14
*
J01DB01
ATC
cefalexin; oral
1.4
12.6
1661
14938
DE2DG
NOMESCO Finland
Acoustic channel very extensive MRI examination with high intensity magnet
32.2
12.6
16
5
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
+∞
12.5
12
*
D33.17
ICD-10 Finland
Fourth ventricle
+∞
12.5
12
*
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
+∞
12.5
12
*
C72.01
ICD-10 Finland
Malignant tumor of the spinal cord grade II glioma
+∞
12.5
12
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
+∞
12.5
12
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
12.5
12
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
12.5
12
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
12.5
12
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
130.7
12.4
13
*
G50.0
ICD-10 Finland
Trigeminal neuralgia
3.7
12.3
53
146
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
37.7
12.2
15
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.1
12.2
46
113
UJF32
NOMESCO Finland
Coloscopy
1.5
12.1
456
3237
A28
ICPC
Limited function/disability NOS
1.7
12.1
268
1666
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
6.8
11.9
29
43
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
11.8
170
918
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
11.8
552
4100
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
11.8
183
1016
ZZF00
NOMESCO Finland
Graft of adipose tissue
14.7
11.8
19
13
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
10.6
11.7
22
21
G44.2
ICD-10 Finland
Tension-type headache
1.7
11.7
256
1584
ZXC86
NOMESCO Finland
Use of endoscopic device
7.4
11.7
27
37
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
11.6
166
897
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
8.6
11.5
24
28
9505/1-C71.9
ICD-O-3
Ganglioglioma, NOS, of brain, NOS
+∞
11.5
11
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
11.5
11
*
9161/1-C72.0
ICD-O-3
Hemangioblastoma of spinal cord
+∞
11.5
11
*
2253A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal cord
+∞
11.5
11
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
11.5
11
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
11.5
11
*
3252
FHL
Repair with foreign material (spring, magnet)
+∞
11.5
11
*
C71.19
ICD-10 Finland
Malignant tumor of frontal lobe other or unspecified histology
+∞
11.5
11
*
C71.30
ICD-10 Finland
Malignant tumor in parietal lobe without histology
+∞
11.5
11
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
11.5
11
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
11.5
11
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
11.5
11
*
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
6.1
11.3
30
50
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
15.1
11.3
18
12
DE2BM
NOMESCO Finland
Acoustic channel MRI examination with 3 Tesla magnet
35.2
11.3
14
*
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
2.9
11.2
66
230
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
17.1
11.2
17
10
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
2.1
11.2
125
611
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
11.2
276
1767
N03AX09
ATC
lamotrigine; oral
2.4
11.1
94
402
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
20.1
11.1
16
8
N03AX11
ATC
topiramate; oral
3.1
11.1
60
198
J01MA12
ATC
levofloxacin; systemic
1.6
11.1
308
2030
N18
ICPC
Paralysis/weakness
3.6
11.1
49
139
N05BA01
ATC
diazepam; systemic, rectal
1.7
11.1
256
1607
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
11.0
413
2924
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
11.0
175
979
QAJ10
NOMESCO Finland
Browlift
11.2
11.0
20
18
D42.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cerebral meninges
43.5
10.9
13
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
43.5
10.9
13
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
9.6
10.7
21
22
KAC10
NOMESCO Finland
Total nephrectomy with capsule
28.1
10.7
14
5
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
17.9
10.7
16
9
R4120
NOMESCO Finland
Occupational therapy
2.0
10.7
128
644
ZXC96
NOMESCO Finland
Robot assisted procedure
6.7
10.7
26
39
AAH50
NOMESCO Finland
Cranial nerve anastomosis
60.3
10.6
12
*
N88
ICPC
Epilepsy
8.0
10.6
23
29
H16.0
ICD-10 Finland
Corneal ulcer
2.3
10.6
97
435
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.0
10.5
131
667
R51
ICD-10 Finland
Headache
2.2
10.5
109
517
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.8
10.5
178
1019
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
2.3
10.5
93
409
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
110.5
10.4
11
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
110.5
10.4
11
*
ZX080
NOMESCO Finland
Image guided radiotherapy
110.5
10.4
11
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
10.4
10
*
N74
ICPC
Malignant neoplasm nervous system
+∞
10.4
10
*
L02BG06
ATC
exemestane; oral
+∞
10.4
10
*
C71.1
ICD-10 Finland
Malignant neoplasm: Frontal lobe
+∞
10.4
10
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
10.4
10
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
10.4
10
*
22599
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Unspecified site
+∞
10.4
10
*
AA1AA
NOMESCO Finland
Head X-ray examination
5.9
10.4
28
48
L57.0
ICD-10 Finland
Actinic keratosis
2.0
10.4
132
678
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.7
10.4
214
1301
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
16.1
10.3
16
10
23810
ICD-8 Finland
Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain
32.7
10.3
13
*
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
8.2
10.3
22
27
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
8.8
10.3
21
24
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
10.3
234
1463
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
10.2
699
5545
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.2
10.0
51
162
B01AB10
ATC
tinzaparin; parenteral
2.3
10.0
90
399
9531/0-C70.0
ICD-O-3
Meningothelial meningioma of cerebral meninges
40.2
10.0
12
*
N40
ICD-10 Finland
Hyperplasia of prostate
1.5
10.0
336
2322
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.6
9.9
248
1593
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
4.1
9.8
37
92
G04BE03
ATC
sildenafil; oral
8.1
9.8
21
26
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
9.8
217
1346
L02BG03
ATC
anastrozole; oral
26.1
9.8
13
5
G91.8
ICD-10 Finland
Other hydrocephalus
26.1
9.8
13
5
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
10.7
9.8
18
17
2377A
ICD-9 Finland
Neoplasm of uncertain behaviour of endocrine glands and nervous system, Neurofibromatosis
55.2
9.6
11
*
2132
FHL
Ventricular operators sunt
55.2
9.6
11
*
G04CA02
ATC
tamsulosin; oral
1.5
9.6
357
2519
ZXD35
NOMESCO Finland
Usual procedure
2.5
9.6
73
299
R50.9
ICD-10 Finland
Fever, unspecified
1.6
9.6
229
1452
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
9.5
510
3867
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
15.1
9.5
15
10
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
9.5
762
6190
WX002
NOMESCO Finland
Sedation and analgesia
1.5
9.5
340
2382
N99
ICPC
Neurological disease other
4.5
9.4
32
72
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.9
9.4
55
192
ZZK00
NOMESCO Finland
Graft of nerve
100.4
9.4
10
*
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
17.6
9.4
14
8
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
9.4
9
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
9.4
9
*
C71.50
ICD-10 Finland
Malignant tumor of cerebral ventricle without histology
+∞
9.4
9
*
D32
ICD-10 Finland
Benign neoplasm of meninges
+∞
9.4
9
*
C71.22
ICD-10 Finland
Malignant tumor of temporal lobe grade III glioma
+∞
9.4
9
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
9.4
9
*
Q85.82
ICD-10 Finland
of Hipple-Lindau syndrome
+∞
9.4
9
*
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
+∞
9.4
9
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
9.4
9
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
9.4
9
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
9.4
9
*
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
+∞
9.4
9
*
C75.3
ICD-10 Finland
Malignant neoplasm: Pineal gland
+∞
9.4
9
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
9.4
9
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
9.4
9
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.3
9.3
45
138
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
3.8
9.3
38
102
H02AB06
ATC
prednisolone; systemic
1.3
9.3
860
7133
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
8.7
9.3
19
22
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.6
9.2
66
259
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
7.3
9.2
21
29
H91.9
ICD-10 Finland
Hearing loss, unspecified
2.2
9.2
87
396
DAX08
NOMESCO Finland
Fitting of hearing aid
2.2
9.2
89
408
H81.3
ICD-10 Finland
Other peripheral vertigo
2.6
9.1
63
245
T88.9
ICD-10 Finland
Complication of surgical and medical care, unspecified
8.3
9.1
19
23
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
5.9
9.0
24
41
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
10.1
9.0
17
17
M03BX01
ATC
baclofen; systemic
3.3
9.0
44
137
ZXY02
NOMESCO Finland
Neuropsychologist
6.5
8.9
22
34
D18.0
ICD-10 Finland
Haemangioma, any site
3.0
8.9
48
160
R20.2
ICD-10 Finland
Paraesthesia of skin
1.9
8.9
125
672
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.5
8.9
65
261
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
8.9
438
3268
PJA10
NOMESCO Finland
Exploration of lymph nodes
8.0
8.8
19
24
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.8
8.7
53
191
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.4
8.7
70
295
102
Kela drug reimbursment
Diabetes insipidus
14.1
8.7
14
10
XX9XW
NOMESCO Finland
NA
6.6
8.6
21
32
J01MA02
ATC
ciprofloxacin; systemic
1.3
8.6
680
5487
N03AE01
ATC
clonazepam; systemic
1.9
8.6
117
621
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.0
8.6
110
569
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.2
8.6
85
395
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.2
8.5
80
364
R51.81
ICD-10 Finland
Facial pain NOS
2.9
8.5
49
169
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.5
8.5
66
274
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
3.3
8.5
41
127
ZXE00
NOMESCO Finland
One hour or less
1.3
8.5
700
5688
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
5.7
8.4
23
41
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
90.4
8.4
9
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
90.4
8.4
9
*
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
90.4
8.4
9
*
QAJ20
NOMESCO Finland
Subperiosteal facelift
90.4
8.4
9
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
90.4
8.4
9
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.7
8.4
55
208
H47.1
ICD-10 Finland
Papilloedema, unspecified
6.7
8.4
20
30
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
8.3
8
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
8.3
8
*
C71.01
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade II glioma
+∞
8.3
8
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
8.3
8
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
8.3
8
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
8.3
8
*
C71.69
ICD-10 Finland
Malignant tumor of the cerebellum other or unspecified histology
+∞
8.3
8
*
C71.6
ICD-10 Finland
Malignant neoplasm: Cerebellum
+∞
8.3
8
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
+∞
8.3
8
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
8.3
8
*
1922A
ICD-9 Finland
Malignant neoplasm of other and unspecified parts of nervous system, Spinal cord
+∞
8.3
8
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
8.3
8
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
8.3
8
*
R4150
NOMESCO Finland
Neuropsychological rehabilitation
5.0
8.3
25
50
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
5.8
8.3
22
38
G40
ICD-10 Finland
Epilepsy
4.5
8.2
27
60
R11
ICD-10 Finland
Nausea and vomiting
1.8
8.1
141
813
TKE00
NOMESCO Finland
Needle biopsy of prostate
3.0
8.1
44
148
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.2
8.1
77
352
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.3
8.1
38
115
WX704
NOMESCO Finland
Intubation
1.9
8.1
122
670
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
33.5
8.1
10
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.9
8.1
108
569
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.8
8.1
133
755
ZX112
NOMESCO Finland
Subcutaneous
4.8
8.1
25
52
119
Kela drug reimbursment
Trigeminal neuralgia or glossofaryngeusneuralgia
6.8
8.1
19
28
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.9
8.0
118
646
R90.0
ICD-10 Finland
Intracranial space-occupying lesion
22.1
8.0
11
5
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.3
8.0
73
328
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
13.1
7.9
13
10
N06AA09
ATC
amitriptyline; systemic
1.6
7.9
187
1185
JN6AD
NOMESCO Finland
CT of torso and neck
7.8
7.9
17
22
M05BX04
ATC
denosumab; parenteral
2.2
7.9
73
332
N06AX16
ATC
venlafaxine; oral
1.5
7.8
243
1645
-
ICD-10 Finland
NA
2.7
7.8
50
187
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.8
7.7
132
758
ZX120
NOMESCO Finland
Intravenous
1.8
7.7
121
676
Z2446
NOMESCO Finland
Social worker
1.9
7.7
115
630
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
45.1
7.7
9
*
2396A
ICD-9 Finland
Neoplasm of unspecified nature, Brain
45.1
7.7
9
*
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
45.1
7.7
9
*
G97.8
ICD-10 Finland
Other postprocedural disorders of nervous system
45.1
7.7
9
*
AWW99
NOMESCO Finland
Other reoperation in surgery of the nervous system
45.1
7.7
9
*
2130
FHL
Ventricular atrial shunt
45.1
7.7
9
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.9
7.7
107
572
G82.2
ICD-10 Finland
Paraplegia, unspecified
7.4
7.7
17
23
R1260
NOMESCO Finland
Evaluation of communicative skills
3.1
7.6
40
132
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
7.6
421
3198
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
7.6
234
1578
H02.1
ICD-10 Finland
Ectropion of eyelid
4.7
7.6
24
51
ZXA10
NOMESCO Finland
Bilateral
1.4
7.6
328
2380
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.3
7.6
66
291
Z2221
NOMESCO Finland
Medical doctor
1.4
7.6
476
3695
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
25.1
7.6
10
*
AWC00
NOMESCO Finland
Reoperation of nervous system because of deep wound infection in the nervous system
25.1
7.6
10
*
AAK00
NOMESCO Finland
Cranioplasty
25.1
7.6
10
*
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.9
7.5
44
155
HAB99
NOMESCO Finland
Other partial excision of mammary gland
5.2
7.5
22
43
M03BX02
ATC
tizanidine; oral
1.3
7.5
1182
10442
Z97.4
ICD-10 Finland
Presence of external hearing-aid
2.1
7.5
85
421
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
2.4
7.5
60
255
N28
ICPC
Limited function/disability (N)
3.1
7.5
38
123
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
7.4
201
1318
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
80.3
7.4
8
*
E22.80
ICD-10 Finland
Central precocious puberty
80.3
7.4
8
*
AAA00
NOMESCO Finland
Exploratory craniotomy
80.3
7.4
8
*
74340
ICD-8 Finland
Other congenital anomalies of nervous system, Neurofibromatosis
80.3
7.4
8
*
CBK10
NOMESCO Finland
Operation for lagophtalmus
80.3
7.4
8
*
K07.60
ICD-10 Finland
Snapping jaw
2.0
7.3
86
433
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
7.3
7
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
7.3
7
*
2139
FHL
Other measure in this category
+∞
7.3
7
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
7.3
7
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
7.3
7
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
7.3
7
*
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
7.3
7
*
Q85.9
ICD-10 Finland
Phakomatosis, unspecified
+∞
7.3
7
*
C72.9
ICD-10 Finland
Malignant neoplasm: Central nervous system, unspecified
+∞
7.3
7
*
2311
FHL
Resection
+∞
7.3
7
*
C71.89
ICD-10 Finland
Overall malignant tumor of the brain other or unspecified histology
+∞
7.3
7
*
L01CA04
ATC
vinorelbine; systemic
+∞
7.3
7
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
7.3
7
*
9413/0-C71.9
ICD-O-3
Dysembryoplastic neuroepithelial tumor of brain, NOS
+∞
7.3
7
*
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
+∞
7.3
7
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
7.3
7
*
3259
FHL
Other measure in this category
+∞
7.3
7
*
9361/1-C75.3
ICD-O-3
Pineocytoma of pineal gland
+∞
7.3
7
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
7.3
7
*
C71.09
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles other or unspecified histology
+∞
7.3
7
*
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
+∞
7.3
7
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
7.3
7
*
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
D16.6
ICD-10 Finland
Benign neoplasm: Vertebral column
+∞
7.3
7
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
7.3
7
*
SPAT1229
SPAT
Assessment of need for aid
1.7
7.3
142
850
CBF99
NOMESCO Finland
Other operation for ectropion
10.9
7.3
13
12
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
7.2
538
4282
R33
ICD-10 Finland
Retention of urine
1.8
7.2
122
700
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
2.8
7.2
43
155
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
7.2
118
669
G04CA01
ATC
alfuzosin; oral
1.6
7.2
181
1164
CBK99
NOMESCO Finland
Other operation for retraction of eyelid
30.1
7.1
9
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
7.1
298
2149
SPAT1043
SPAT
Audiometry
1.6
7.1
196
1287
R5140
NOMESCO Finland
Monitoring the use of the aid
1.6
7.1
199
1312
TQW20
NOMESCO Finland
Tatoe
20.1
7.1
10
5
CBW99
NOMESCO Finland
Other operation on eyelid
20.1
7.1
10
5
J01FF01
ATC
clindamycin; systemic
1.4
7.1
476
3729
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
3.0
7.1
38
128
TAC00
NOMESCO Finland
Peripheral nerve block
7.9
7.1
15
19
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
12.1
7.1
12
10
H02
ICPC
Hearing complaint
1.5
7.1
219
1481
AAF15
NOMESCO Finland
Ventriculoatrial shunt
8.8
7.0
14
16
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
10.0
7.0
13
13
N06AX21
ATC
duloxetine; oral
1.6
7.0
193
1269
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.8
7.0
111
624
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.8
7.0
124
725
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
3.3
6.9
32
97
ZZR10
NOMESCO Finland
Flap of skin and muscle
13.8
6.9
11
8
D48.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Peripheral nerves and autonomic nervous system
13.8
6.9
11
8
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.8
6.8
117
673
R1250
NOMESCO Finland
Evaluation of functional capability
2.5
6.8
49
197
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
3.4
6.8
31
93
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
6.7
6.8
16
24
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.8
6.8
111
629
D43.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cranial nerves
40.2
6.8
8
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
40.2
6.8
8
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
40.2
6.8
8
*
AAF50
NOMESCO Finland
Third ventriculostomy
16.7
6.7
10
6
TQW99
NOMESCO Finland
Other minor procedure on skin
2.2
6.7
62
280
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.9
6.7
88
465
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.0
6.7
85
440
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
7.2
6.7
15
21
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
22.6
6.7
9
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
22.6
6.7
9
*
AAA10
NOMESCO Finland
Biopsy through craniotomy
22.6
6.7
9
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
22.6
6.7
9
*
9532/0-C70.0
ICD-O-3
Fibrous meningioma of cerebral meninges
22.6
6.7
9
*
Z00.0
ICD-10 Finland
General medical examination
1.4
6.7
335
2499
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
3.8
6.7
26
69
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.1
6.6
69
332
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
6.6
171
1111
XF400
NOMESCO Finland
ECG with 12 standard connections
1.4
6.6
276
1992
D06BB10
ATC
imiquimod; topical
2.1
6.6
71
347
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.5
6.5
49
200
R53
ICD-10 Finland
Malaise and fatigue
1.4
6.5
349
2634
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
4.0
6.5
24
61
RK520
NOMESCO Finland
NA
6.2
6.5
16
26
H50.2
ICD-10 Finland
Vertical strabismus
4.5
6.5
21
47
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
3.4
6.4
29
87
CBC10
NOMESCO Finland
Removal of foreign body from eyelid
70.0
6.4
7
*
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
70.0
6.4
7
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
70.0
6.4
7
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
4.9
6.3
19
39
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.4
6.3
343
2594
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.7
6.3
39
145
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
11.0
6.3
11
10
TQA05
NOMESCO Finland
Puncture of skin of head or neck
18.1
6.3
9
5
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
6.3
6
*
1CD02
NOMESCO Finland
NA
+∞
6.3
6
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
6.3
6
*
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
+∞
6.3
6
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
6.3
6
*
9505/1-C71.2
ICD-O-3
Ganglioglioma, NOS, of temporal lobe
+∞
6.3
6
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
6.3
6
*
L01XE04
ATC
[U] sunitinib; oral
+∞
6.3
6
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
6.3
6
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
6.3
6
*
9421/1-C72.0
ICD-O-3
Pilocytic astrocytoma of spinal cord
+∞
6.3
6
*
C43.60
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder without histology
+∞
6.3
6
*
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
+∞
6.3
6
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
6.3
6
*
C71.59
ICD-10 Finland
Malignant tumor of cerebral ventricle other or unspecified histology
+∞
6.3
6
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
6.3
6
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
6.3
6
*
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
6.3
6
*
C71.51
ICD-10 Finland
Malignant tumor of cerebral ventricle ependymoma
+∞
6.3
6
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
+∞
6.3
6
*
3253
FHL
Tarsoraphy
+∞
6.3
6
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
6.3
6
*
197
Kela drug reimbursment
Sunitinib
+∞
6.3
6
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
6.3
6
*
C71.23
ICD-10 Finland
Malignant tumor of temporal lobe grade IV glioma
+∞
6.3
6
*
9400/3-C71.9
ICD-O-3
Astrocytoma, NOS, of brain, NOS
+∞
6.3
6
*
9560/0-C71.9
ICD-O-3
Schwannoma, NOS, of brain, NOS
+∞
6.3
6
*
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.9
6.2
82
434
3314A
ICD-9 Finland
Other cerebral degenerations, Obstructive hydrocephalus
26.7
6.2
8
*
D42.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Meninges, unspecified
26.7
6.2
8
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
26.7
6.2
8
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
26.7
6.2
8
*
RK320
NOMESCO Finland
NA
4.3
6.2
21
49
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
6.2
229
1610
RS222
NOMESCO Finland
NA
3.5
6.2
26
74
A02BA02
ATC
ranitidine; systemic
1.4
6.2
333
2517
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
6.1
644
5368
D35.30
ICD-10 Finland
Craniopharyngoma
12.5
6.1
10
8
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.7
6.1
24
65
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
3.3
6.1
28
86
M54.5
ICD-10 Finland
Low back pain
1.3
6.0
593
4895
N05CF01
ATC
zopiclone; oral
1.3
6.0
547
4465
H90.5
ICD-10 Finland
Sensorineural hearing loss, unspecified
3.4
6.0
27
81
H01AC01
ATC
somatropin; parenteral
6.7
6.0
14
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
387
582
7.69
251.98
1.3
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
188
102
19.86
239.40
1.6
2.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
521
1969
3.08
101.90
7.0
7.0
mmol/l
1.2
1.3
0.21
393
1521
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
518
1988
3.03
98.31
7.1
7.0
kpa
5.1
5.1
0.21
498
1890
(3027801) Oxygen [Partial pressure] in Arterial blood
518
1988
3.03
98.31
7.1
7.0
kpa
16.2
11.8
32.11
496
1890
(3044640) Blood type and Crossmatch panel - Blood
998
5333
2.46
97.66
2.3
2.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
309
873
3.90
95.34
7.2
9.1
mmol/l
24.3
24.4
0.44
298
800
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1338
8308
2.33
90.82
6.9
5.2
mmol/l
1.2
1.2
2.40
1258
7372
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1422
9252
2.26
83.71
7.5
5.6
mmol/l
1.2
1.2
1.28
1280
7767
(40768804) Tissue Pathology biopsy report
1105
6531
2.25
81.85
2.4
1.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
836
4500
2.29
76.54
3.7
3.5
%
92.8
89.7
3.06
817
4384
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
777
4113
2.30
73.51
2.2
2.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
112
168
6.93
71.55
2.4
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1268
8313
2.08
67.81
3.9
3.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1587
11321
2.12
67.28
5.7
4.2
mmol/l
6.5
6.7
4.06
1523
10499
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
78
87
9.22
63.91
2.0
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
158
401
4.14
55.91
2.0
1.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
160
442
3.80
50.27
1.9
1.3
e6/l
44.9
28.6
0.27
123
343
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
160
442
3.80
50.27
2.0
1.4
e6/l
1186.2
1402.1
0.09
127
360
(3014007) Fractional oxyhemoglobin in Arterial blood
276
1068
2.78
49.61
8.9
8.7
%
94.9
93.4
3.09
276
1063
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
171
499
3.61
49.56
1.8
1.2
mg/l
644.4
482.9
2.41
164
465
(3016018) Differential panel - Cerebral spinal fluid
100
196
5.27
48.56
2.1
1.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1282
9077
1.85
48.49
6.3
3.9
umol/l
10.9
11.9
2.05
1225
8461
(3002173) Hemoglobin [Mass/volume] in Arterial blood
359
1616
2.43
47.19
8.7
7.8
g/l
124.5
123.0
0.73
353
1553
(3016502) Oxygen saturation in Arterial blood
381
1774
2.36
46.37
8.4
7.4
%
96.8
95.3
4.61
374
1700
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
234
904
2.75
41.98
3.7
1.5
ug/l
9.1
3.3
0.79
190
672
(3032080) INR in Blood by Coagulation assay
1061
7356
1.77
40.61
6.1
9.3
inr
1.2
1.3
5.06
261
2174
(3024561) Albumin [Mass/volume] in Serum or Plasma
1086
7664
1.74
38.42
4.7
3.9
g/l
35.7
36.0
0.78
1011
7044
(3013650) Neutrophils [#/volume] in Blood by Automated count
1402
10744
1.70
35.68
9.0
6.5
e9/l
4.2
4.2
0.12
1203
9272
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
139
440
3.29
35.38
1.7
1.2
mmol/l
3.6
3.8
2.11
128
408
(3014576) Chloride [Moles/volume] in Serum or Plasma
407
2159
2.06
35.12
7.7
6.2
mmol/l
104.7
104.1
1.54
398
2106
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
56
92
6.20
32.74
2.6
2.2
umol/l
51.6
52.6
0.08
50
70
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1768
14699
1.71
30.64
8.0
5.4
u/l
76.6
76.3
0.10
1686
13620
(3002256) Pathology report gross observation
314
1588
2.12
30.52
1.3
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
463
2688
1.89
30.38
3.2
2.7
mmol/l
0.8
0.8
0.05
434
2472
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
884
6201
1.66
29.88
2.4
2.1
u/l
205.8
229.9
0.29
851
5808
(3023410) Appearance of Cerebral spinal fluid
81
200
4.15
29.69
2.0
1.5
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
66
146
4.62
27.84
2.1
1.1
mmol/l
2.7
2.1
1.24
61
136
(3018677) aPTT in Platelet poor plasma by Coagulation assay
468
2800
1.83
27.67
2.0
2.0
s
29.1
29.8
1.46
460
2705
(3018418) pH of Serum or Plasma
775
5339
1.66
27.64
4.2
3.2
ph
7.4
7.4
0.38
116
917
(3026008) Bacteria identified in Urine by Culture
801
5577
1.64
27.33
3.3
3.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
27
22
12.40
27.25
6.0
1.0
u/ml
27.0
17.9
1.26
27
22
(3000991) Gas panel - Venous blood
287
1484
2.06
26.12
8.4
7.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
833
5908
1.62
26.12
3.4
2.0
mmol/l
2.4
2.4
0.05
710
4979
(3019550) Sodium [Moles/volume] in Serum or Plasma
2285
20847
2.23
25.82
20.3
13.9
mmol/l
139.7
139.8
0.25
2259
20274
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
27
24
11.36
25.80
1.2
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
324
1773
1.95
25.08
3.1
1.8
nmol/l
336.5
360.1
1.40
301
1618
(3023103) Potassium [Moles/volume] in Serum or Plasma
2286
20916
2.19
24.70
20.2
14.0
mmol/l
3.9
4.0
4.67
2257
20307
(3014111) Lactate [Moles/volume] in Serum or Plasma
291
1543
2.00
24.65
8.0
6.4
mmol/l
1.3
1.4
1.31
281
1488
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
42
72
5.92
23.55
2.7
2.7
umol/l
28.9
29.9
0.24
34
51
(3023368) Bacteria identified in Blood by Culture
668
4585
1.63
23.46
4.4
3.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2217
20191
1.93
22.27
17.1
11.9
mg/l
23.5
22.2
1.04
1848
15472
(3031040) Bacteria [#/volume] in Urine by Automated count
1527
12691
1.53
22.23
5.5
4.2
e6/l
606.1
1574.4
1.10
22
166
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
73
211
3.53
21.46
5.2
7.3
mg/l
9.9
11.6
2.54
64
194
(3001604) Monocytes [#/volume] in Blood
1220
9720
1.50
21.38
6.2
5.5
e9/l
0.6
0.6
0.46
1025
8387
(3019060) Gas panel - Arterial blood
230
1182
2.04
21.16
6.4
4.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
654
4565
1.59
21.04
6.2
4.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
1222
9772
1.49
20.83
6.2
5.5
e9/l
0.0
0.0
0.91
1025
8443
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
24
25
9.68
20.56
1.1
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
489
3197
1.66
20.48
3.0
2.1
mmol/l
2.4
2.4
0.05
420
2737
(3019198) Lymphocytes [#/volume] in Blood
1243
10010
1.48
20.23
6.3
5.6
e9/l
1.9
1.9
1.00
1057
8802
(3013115) Eosinophils [#/volume] in Blood
1254
10127
1.48
20.05
6.4
5.7
e9/l
0.2
0.2
1.84
1067
8877
(3043409) Potassium [Moles/volume] in Arterial blood
131
554
2.44
19.38
5.2
4.2
mmol/l
3.8
3.9
1.68
122
521
(3008152) Bicarbonate [Moles/volume] in Arterial blood
218
1135
2.01
19.31
9.2
6.9
mmol/l
25.3
24.6
2.26
209
1049
(3020779) Urea [Moles/volume] in Serum or Plasma
277
1568
1.86
19.14
5.3
7.1
mmol/l
8.5
9.8
2.00
263
1493
(42870588) Differential panel, method unspecified - Blood
849
6390
1.50
18.98
6.5
5.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1590
13561
1.48
18.62
5.0
4.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
693
5027
1.53
18.35
3.6
2.9
e6/l
0.4
0.4
0.05
545
3744
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
179
888
2.09
18.07
10.8
10.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
742
5489
1.50
17.79
3.6
3.0
e6/l
35.9
88.4
2.07
591
4154
(3020891) Body temperature
158
754
2.17
17.63
6.2
4.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
462
3090
1.61
17.38
2.9
2.5
e6/l
1.0
1.2
0.51
269
1742
(36304419) Bacteria [Presence] in Urine
677
4934
1.51
17.37
3.5
2.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
371
2354
1.68
17.19
5.2
5.4
mmol/l
1.0
1.0
1.23
342
2176
(3022096) Basophils/100 leukocytes in Blood
1094
8778
1.44
17.07
6.3
5.8
%
0.7
0.7
0.09
1020
8138
(3018095) Leukocytes [#/volume] in Urine
862
6619
1.46
16.96
4.1
3.4
e6/l
70.5
91.9
0.23
640
4519
(3026782) Osmolality of Urine
507
3485
1.57
16.93
2.9
2.6
mosm/kgh2o
547.5
546.1
0.04
430
2930
(3000850) Epithelial cells [#/volume] in Urine
544
3803
1.55
16.85
2.8
2.4
e6/l
4.4
5.9
2.65
482
3303
(3019069) Monocytes/100 leukocytes in Blood
1121
9085
1.43
16.30
6.7
6.0
%
8.8
8.6
1.10
1048
8451
(3006504) Eosinophils/100 leukocytes in Blood
1115
9042
1.42
16.08
6.4
5.7
%
2.8
2.9
1.10
1038
8374
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
283
1715
1.73
15.45
4.1
3.1
u/l
240.2
234.9
0.26
265
1607
(3002030) Lymphocytes/100 leukocytes in Blood
1141
9345
1.41
15.28
6.5
5.8
%
27.8
28.5
1.39
1065
8665
(3035637) Corticotropin [Mass/volume] in Plasma
60
191
3.19
15.23
1.7
1.5
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
75
274
2.79
14.96
2.1
1.3
nmol/l
0.1
0.5
—
8
19
(3018010) Neutrophils/100 leukocytes in Blood
1127
9252
1.40
14.69
6.2
5.6
%
57.2
56.9
0.45
1058
8609
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
426
2909
1.56
14.43
1.8
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
379
2537
1.58
13.97
7.1
6.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1690
14932
1.41
13.88
4.4
4.1
mm/h
11.1
11.4
0.44
1571
13828
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1017
8268
1.39
13.74
2.4
2.3
nmol/l
77.3
77.5
0.10
918
7352
(3009214) Lutropin [Units/volume] in Serum or Plasma
108
492
2.25
13.54
2.0
1.4
u/l
7.6
8.5
0.31
82
400
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
68
249
2.78
13.53
2.2
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
412
2837
1.54
13.37
3.1
2.7
e6/l
2.4
2.9
0.52
224
1499
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
235
1410
1.74
13.25
2.6
2.3
au/ml
24.6
25.6
0.04
15
65
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
66
242
2.77
13.11
2.0
1.3
nmol/l
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2052
18872
1.51
13.01
15.3
10.7
ml/min/173m2
83.2
81.2
3.83
1754
15109
(40768800) Prostate Pathology biopsy report
38
101
3.81
12.72
1.1
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
130
655
2.04
12.62
2.3
1.6
mu/l
427.2
306.0
1.39
125
593
(3007853) Bacteria identified in Skin by Aerobe culture
327
2175
1.58
12.31
1.7
1.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
213
1272
1.74
12.20
1.4
1.3
au/ml
38.8
44.6
0.18
12
55
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
81
342
2.41
12.12
3.6
2.0
u/ml
114.9
92.8
0.13
74
273
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1758
15800
1.39
11.89
4.6
3.9
pmol/l
14.8
14.7
0.64
1609
14371
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
748
5898
1.38
11.69
2.8
2.3
u/l
57.5
58.2
0.11
688
5416
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
915
7455
1.36
11.64
3.6
3.6
ng/l
35.3
65.8
1.43
634
4977
(40768793) Breast Pathology biopsy report
44
145
3.07
10.63
1.3
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
14
17
8.28
10.61
3.8
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
66
272
2.47
10.45
1.3
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
178
1057
1.74
10.41
1.7
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
35
105
3.37
9.86
1.2
1.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
28
72
3.92
9.85
1.2
1.1
ng/l
75.6
40.0
—
8
14
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
763
6172
1.34
9.77
3.6
2.7
u/l
34.0
35.4
0.16
725
5840
(40761511) CBC panel - Blood by Automated count
2230
21136
1.55
9.62
15.8
11.5
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
61
254
2.44
9.47
1.6
1.4
mu/l
39.2
54.5
0.56
51
227
(40761535) Cells panel - Urine sediment
247
1636
1.57
9.41
3.7
3.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
642
5086
1.35
9.37
1.4
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
104
541
1.96
9.30
2.5
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
347
2476
1.47
9.29
2.2
2.0
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
220
1428
1.59
9.14
2.3
2.2
g/l
0.2
0.2
0.38
205
1308
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2018
18819
1.39
9.01
5.3
4.7
mu/l
1.9
2.0
1.23
1852
17231
(3019225) pH of Specimen
272
1859
1.52
8.98
4.2
3.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
586
4620
1.35
8.75
4.2
3.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
188
1190
1.63
8.66
1.6
1.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
194
1241
1.61
8.57
2.7
2.3
nmol/l
12.1
13.9
2.30
170
1105
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
32
100
3.23
8.49
1.2
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
49
195
2.54
8.41
1.1
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
579
4589
1.34
8.29
1.6
1.5
nmol/l
20.6
20.9
0.13
494
3867
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
39
139
2.83
8.28
1.1
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1129
9793
1.28
8.25
4.4
3.5
estimate
0.0
0.0
1.34
190
1668
(3021589) Normoblasts [#/volume] in Blood
1012
8661
1.28
8.22
10.0
8.2
e9/l
0.0
0.0
0.26
781
7087
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
48
192
2.53
8.16
2.0
1.8
u/ml
12.8
38.8
1.62
39
171
(3044889) 12 lead EKG panel
1554
14040
1.29
8.14
3.8
3.7
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
11
5
22.09
8.01
1.7
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
56
243
2.33
7.99
1.3
1.4
pmol/l
265.4
307.2
0.40
45
185
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2263
21646
1.52
7.92
11.7
8.8
u/l
26.1
26.0
0.09
2207
20771
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
286
2034
1.46
7.75
1.8
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1111
9674
1.27
7.68
4.3
3.5
estimate
0.0
0.0
0.00
186
1690
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1459
13128
1.27
7.65
3.7
3.0
u/l
49.2
44.8
1.24
1384
12177
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
286
2040
1.45
7.63
1.9
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1112
9692
1.27
7.59
5.7
4.7
estimate
0.0
0.0
0.50
191
1727
(3052851) Hemolysis interference index of Serum or Plasma
96
522
1.87
7.58
2.7
3.5
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
10
12
8.36
7.58
1.0
1.4
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
38
141
2.72
7.51
1.1
1.1
mg/l
302.2
246.4
0.77
32
121
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
603
4868
1.32
7.49
2.3
2.2
mg/l
3.0
2.8
0.89
504
4133
(40768797) Stomach Pathology biopsy report
356
2663
1.39
7.28
1.2
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
33
116
2.87
7.22
1.1
1.1
u/l
1.0
1.1
0.85
16
59
(3023323) Follitropin [Units/volume] in Serum or Plasma
128
775
1.69
7.05
1.8
1.4
iu/l
29.4
27.6
0.23
110
653
(43055514) Macroprolactin [Presence] in Serum or Plasma
18
43
4.21
7.01
1.5
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
181
1200
1.55
6.89
3.4
3.6
kpa
5.1
5.2
0.53
161
1112
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
955
8242
1.26
6.88
2.1
2.0
pmol/l
95.3
96.2
0.24
512
4209
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
220
1522
1.49
6.86
2.6
2.3
ml/min/173m2
72.3
67.5
0.27
78
587
(40768795) Lymph node Pathology biopsy report
17
40
4.27
6.75
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
113
676
1.70
6.52
1.6
1.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
131
818
1.64
6.43
1.9
1.9
u/l
38.1
38.7
0.14
115
714
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
438
3456
1.32
6.30
3.1
2.6
ug/l
0.8
0.7
0.52
299
2221
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
119
729
1.66
6.30
1.6
1.7
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
0
+∞
6.25
1.0
0.0
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
50
231
2.19
6.23
1.7
1.5
nmol/l
0.3
0.3
1.01
40
192
(3009343) pH of Capillary blood
175
1185
1.51
6.07
3.4
3.6
ph
7.4
7.4
0.11
17
136
(3007461) Platelets [#/volume] in Blood
2340
22697
1.55
5.96
25.5
17.5
e9/l
252.2
251.7
0.14
2300
22043
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
169
1143
1.51
5.90
3.3
3.6
mmol/l
1.3
1.8
1.09
122
832
(3008757) Leukocyte morphology finding [Identifier] in Blood
35
142
2.49
5.86
3.2
3.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
137
887
1.58
5.82
3.5
3.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
2340
22710
1.54
5.79
25.5
17.5
fl
90.6
90.9
2.89
2323
22347
(3026361) Erythrocytes [#/volume] in Blood
2340
22715
1.54
5.72
25.5
17.5
e12/l
4.5
4.5
3.47
2300
21989
(3001122) Ferritin [Mass/volume] in Serum or Plasma
972
8533
1.23
5.69
2.8
2.8
ug/l
118.3
113.3
0.24
889
7881
(3000963) Hemoglobin [Mass/volume] in Blood
2340
22721
1.53
5.64
25.7
17.6
g/l
134.6
136.7
10.24
2327
22359
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
315
2405
1.35
5.64
2.6
2.6
%
22.3
23.6
0.76
273
2043
(3035941) MCH [Entitic mass]
2339
22711
1.53
5.62
25.4
17.5
pg
30.2
30.3
2.94
2321
22347
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
84
485
1.76
5.55
1.7
1.7
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
32
128
2.52
5.53
1.0
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2339
22718
1.52
5.53
25.6
17.6
e9/l
6.8
6.7
1.45
2300
21987
(3022145) Colonoscopy Study observation
267
1992
1.38
5.53
1.4
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
584
4865
1.26
5.46
4.6
3.6
%
21.7
23.9
2.95
311
2215
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
19
57
3.35
5.44
1.1
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
42
192
2.21
5.41
1.9
1.4
mosm/kgh2o
283.3
278.5
0.78
32
149
(3013512) EKG study
665
5631
1.25
5.39
4.3
3.8
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
19
58
3.29
5.30
1.1
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
268
2016
1.37
5.27
2.3
2.3
%
1.8
1.8
0.02
232
1763
(3039000) Anion gap in Blood
70
389
1.82
5.27
8.8
7.4
mmol/l
10.3
11.2
1.45
65
346
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
22
74
2.99
5.26
1.2
1.1
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
70
390
1.82
5.23
8.8
7.4
mmol/l
106.3
105.0
1.33
65
347
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
84
495
1.72
5.19
2.7
3.6
u/ml
0.4
0.4
0.02
46
298
(3047181) Lactate [Moles/volume] in Blood
92
558
1.67
5.12
8.0
6.3
mmol/l
1.2
1.2
0.00
81
485
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
65
3.09
5.06
1.4
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
165
1148
1.47
5.05
3.1
3.0
pmol/l
4.4
4.5
0.84
150
1004
(3036489) Thrombin time
108
685
1.60
5.04
2.2
2.0
s
21.4
21.1
0.33
94
598
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
19
60
3.18
5.04
1.1
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
60
3.18
5.04
1.1
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
23
4.80
5.01
1.0
1.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
450
3668
1.28
5.01
1.8
1.7
nmol/l
1170.4
1171.6
0.01
344
2765
(3029937) Albumin [Presence] in Urine by Test strip
613
5183
1.24
4.98
5.1
3.8
estimate
0.0
0.0
1.08
188
1687
(3019150) Specific gravity of Urine by Refractometry
526
4372
1.26
4.97
4.8
3.8
kg/l
1.0
1.0
0.13
75
626
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1399
12843
1.20
4.92
2.9
3.0
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
42
201
2.11
4.87
3.4
2.7
%
1.2
1.0
0.17
35
148
(3023520) Reticulocytes [#/volume] in Blood
204
1487
1.41
4.86
2.7
2.3
e9/l
66.9
70.6
0.93
153
1123
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
221
1635
1.39
4.83
2.6
2.2
u/l
31.0
67.1
0.64
184
1367
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
113
737
1.56
4.71
6.6
5.1
%
1.6
1.6
0.13
106
690
(3007930) Methemoglobin/Hemoglobin.total in Blood
112
730
1.56
4.68
6.6
5.1
%
0.9
0.9
0.93
105
685
(3004789) Transferrin [Mass/volume] in Serum or Plasma
331
2615
1.31
4.68
2.4
2.5
g/l
2.3
2.3
0.20
300
2413
(3005719) IgG [Mass/volume] in Serum or Plasma
185
1335
1.42
4.68
3.2
2.3
g/l
10.2
10.6
0.50
169
1218
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
22
80
2.77
4.61
2.8
1.1
u/ml
390.5
69.1
—
7
22
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
30
128
2.36
4.58
1.2
1.1
nmol/l
0.1
8.3
—
6
28
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
65
370
1.78
4.57
1.3
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
100
640
1.59
4.53
2.2
1.7
ug/l
2.2
1.7
0.36
85
556
(4027681)
28
117
2.41
4.47
1.2
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
700
6063
1.22
4.44
5.3
3.7
ug/l
3.2
1.9
1.66
627
5455
(3021447) Carbon dioxide [Partial pressure] in Venous blood
233
1764
1.35
4.42
3.8
3.5
kpa
5.8
5.9
0.20
228
1704
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
44
223
1.99
4.41
2.2
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
286
2236
1.32
4.36
1.6
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
628
7250
0.82
4.34
2.8
2.9
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
116
777
1.52
4.31
3.4
3.9
mmol/l
24.9
24.7
0.62
105
724
(3022948) Iron [Moles/volume] in Serum or Plasma
357
2879
1.28
4.31
2.4
2.5
umol/l
13.0
13.6
0.67
325
2649
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
10
22
4.56
4.30
1.4
1.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
230
1754
1.34
4.17
3.9
3.5
mmol/l
2.1
2.0
0.05
199
1429
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
78
480
1.65
4.17
1.4
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
172
1252
1.40
4.16
1.4
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
147
1043
1.44
4.11
1.5
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
129
894
1.47
4.08
1.9
2.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1834
17404
1.21
4.03
22.0
15.5
g/l
332.7
332.7
0.01
1824
17275
(3037756) Immunofixation for Serum or Plasma
55
310
1.79
4.03
1.3
1.2
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
24
99
2.44
3.97
3.0
1.2
%
72.0
51.6
—
5
9
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
16
53
3.03
3.96
1.1
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
80
503
1.61
3.94
2.7
2.4
%
171.8
179.3
0.37
74
475
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
10
24
4.18
3.88
1.2
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
23
95
2.43
3.80
1.1
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
11
29
3.81
3.80
1.4
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
12
34
3.54
3.76
1.7
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
312
2517
1.27
3.76
4.9
4.6
%
32.2
32.5
0.16
219
1690
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
249
1951
1.31
3.75
2.7
2.4
umol/l
7.6
7.4
0.06
217
1670
(3009466) Valproate [Moles/volume] in Serum or Plasma
54
310
1.76
3.75
5.7
5.2
umol/l
372.8
367.2
0.11
48
265
(3017143) Hepatitis C virus Ab [Presence] in Serum
258
2035
1.30
3.71
1.7
1.5
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
10
25
4.01
3.70
1.2
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
31
148
2.11
3.69
3.2
2.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
60
358
1.69
3.64
2.5
3.1
umol/l
32.9
37.3
0.57
52
315
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
46
254
1.83
3.63
1.1
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
89
587
1.54
3.61
2.8
1.4
g/l
1.4
0.4
1.47
72
512
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
192
1461
1.34
3.56
4.1
3.9
ng/l
85.3
87.0
0.10
170
1257
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
835
7478
1.18
3.50
4.7
3.6
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
13
6.17
3.50
1.0
1.1
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
121
857
1.43
3.46
3.5
2.5
%
0.7
0.7
0.55
115
819
(3020630) Protein [Mass/volume] in Serum or Plasma
189
1443
1.34
3.44
2.9
1.5
g/l
66.3
67.1
0.75
165
1306
(4024509)
35
180
1.96
3.43
1.7
1.8
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
10
27
3.71
3.35
2.6
2.2
umol/l
46.0
46.5
—
10
22
(4268621)
38
203
1.89
3.35
2.5
2.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
45
254
1.79
3.34
1.7
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
75
486
1.56
3.31
1.9
2.0
mg/l
10.8
11.3
0.26
69
444
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
629
5527
1.18
3.28
2.9
3.0
ng/l
1047.5
1354.4
1.40
532
4677
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
18
72
2.51
3.21
1.1
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
30
150
2.01
3.20
1.7
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
33
171
1.94
3.19
1.6
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1766
16829
1.17
3.16
20.3
14.3
%
13.7
13.6
1.38
1739
16404
(3003181) Sodium [Moles/volume] in Urine
53
319
1.68
3.16
1.8
1.5
mmol/l
73.9
61.8
0.97
46
260
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
62
391
1.60
3.09
1.1
1.3
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
11
34
3.25
3.06
1.1
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
75
496
1.53
3.05
3.3
1.5
ratio
2.2
1.7
—
5
48
(3022217) INR in Platelet poor plasma by Coagulation assay
301
2482
1.24
3.02
21.4
25.8
inr
1.4
1.4
0.37
35
364
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
55
339
1.64
3.01
1.6
1.7
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
27
133
2.04
3.01
3.0
2.7
%
57.3
56.7
0.04
20
85
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
17
4.72
2.92
1.1
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
46
2.84
2.92
1.2
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
443
3815
1.20
2.89
3.9
3.7
ng/l
144.5
470.2
5.03
345
2915
(3011412) CD3 cells [#/volume] in Blood
24
115
2.10
2.88
2.4
2.2
e9/l
1.0
1.2
0.50
13
63
(40768443) Skin Pathology biopsy report
105
752
1.41
2.88
1.2
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
53
328
1.63
2.87
3.7
2.9
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
7
13
5.40
2.87
1.1
1.5
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
7
13
5.40
2.87
1.0
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
84
578
1.47
2.85
2.0
2.1
u/l
9277.3
3847.7
0.64
19
241
(3045424) Erythrocytes [Presence] in Urine
52
325
1.61
2.72
1.7
1.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
68
453
1.52
2.71
3.2
3.1
mmol/l
24.2
25.0
0.79
56
397
(40760888) Immunoglobulin light chains.free panel - Serum
58
374
1.56
2.68
4.0
1.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
8
19
4.22
2.67
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
83
578
1.45
2.67
1.2
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
75
512
1.48
2.67
3.5
1.5
mg/l
35.2
44.5
0.30
63
409
(3004588) Protein electrophoresis panel - Serum or Plasma
160
1241
1.31
2.66
2.7
1.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
75
513
1.48
2.64
3.4
1.5
mg/l
47.5
41.9
0.28
63
412
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
135
1025
1.34
2.61
2.6
2.4
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
15
4.68
2.59
1.1
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
38
222
1.72
2.58
1.3
1.4
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
7
7.15
2.55
2.0
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
121
908
1.35
2.54
2.6
2.4
e6/l
0.3
0.3
0.00
116
880
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
36
208
1.74
2.54
1.1
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
10
33
3.04
2.52
1.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
141
1084
1.32
2.52
1.3
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
57
372
1.54
2.52
5.7
3.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
123
927
1.34
2.51
3.9
3.8
mmol/l
24.5
24.2
0.60
113
829
(3037522) Nuclear Ab [Titer] in Serum
329
2793
1.21
2.51
1.3
1.3
titre
542.8
552.3
0.03
65
605
(42529406) Shigella sp [Presence] in Stool by Culture
83
586
1.43
2.50
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
38
225
1.70
2.47
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
47
295
1.60
2.45
1.3
1.2
u/ml
3.0
6.1
1.33
25
126
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
35
203
1.73
2.45
1.1
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
81
572
1.43
2.45
1.2
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
36
211
1.72
2.43
1.1
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
35
204
1.73
2.41
1.1
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
30
167
1.81
2.40
1.3
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
79
558
1.43
2.39
2.1
1.4
g/l
38.9
38.2
0.53
64
471
(3005988) Vibrio sp identified in Specimen by Organism specific culture
35
205
1.72
2.37
1.1
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
49
314
1.57
2.36
3.0
2.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
36
213
1.70
2.36
1.1
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
45
284
1.60
2.31
4.7
5.4
iu/ml
170.1
460.1
—
7
39
(3028433) Virus identified in Specimen by Culture
15
65
2.32
2.31
1.2
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
35
2.86
2.30
1.1
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
22
112
1.97
2.30
1.8
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
36
215
1.68
2.29
1.7
1.4
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
6
13
4.62
2.27
1.2
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
8
23
3.49
2.27
1.1
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
8
23
3.49
2.27
1.0
1.7
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
8
23
3.49
2.27
1.5
1.1
nmol/l
2.6
5.7
—
8
23
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
70
489
1.44
2.26
4.8
3.8
mg/l
1.4
1.5
0.23
63
449
(3050794) Legionella sp Ab [Presence] in Serum
7
18
3.90
2.25
1.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
7
18
3.90
2.25
1.0
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
223
1844
1.23
2.23
4.0
2.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
31
179
1.74
2.22
2.5
2.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
88
645
1.38
2.18
2.4
3.0
g/l
0.3
0.3
0.07
40
219
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
24
3.34
2.18
1.1
1.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
164
1315
1.26
2.16
3.9
3.0
e9/l
4.1
4.1
0.09
119
1003
(40758292) HTLV I+II Ab panel - Serum
6
14
4.29
2.15
1.7
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
47
306
1.55
2.14
1.3
1.2
u/ml
3.8
3.8
0.01
19
107
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
54
364
1.49
2.10
1.8
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
19
95
2.01
2.10
2.2
1.9
e6/l
609.8
834.6
—
9
42
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
11
43
2.57
2.09
2.8
2.6
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
109
833
1.32
2.08
2.3
1.6
u/ml
40.6
21.5
—
5
21
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
53
357
1.50
2.08
1.8
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
570
5144
1.14
2.02
2.6
2.3
umol/l
976.0
5711.8
6.53
499
4446
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
480
4282
1.15
2.01
1.8
1.8
mg/l
1.2
1.1
0.22
357
3225
(3052592) Norovirus Ag [Presence] in Stool
9
32
2.82
2.00
2.0
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
28
163
1.73
1.98
2.1
4.0
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
73
529
1.39
1.97
2.2
1.4
g/l
0.1
0.0
0.61
66
484
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
86
642
1.35
1.94
1.5
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
42
274
1.54
1.92
1.4
1.2
—
—
—
0
0
(3010421) pH of Blood
63
447
1.42
1.92
7.7
3.9
ph
7.4
7.4
0.00
48
366
(3028026) IgM [Mass/volume] in Serum or Plasma
133
1058
1.27
1.90
2.4
1.4
g/l
2.2
1.1
1.18
115
968
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
102
784
1.31
1.89
1.6
1.7
g/l
1.6
1.5
0.46
90
679
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
68
494
1.39
1.82
2.3
1.4
g/l
0.0
0.0
0.00
61
450
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
67
486
1.39
1.82
2.3
1.4
g/l
0.0
0.0
0.00
61
449
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
668
1.33
1.80
2.1
1.4
g/l
3.0
3.0
0.31
65
522
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2034
19835
1.14
1.79
4.9
4.6
mmol/l
5.8
5.9
5.61
1856
18105
(3017181) Myelocytes/100 leukocytes in Blood
180
1494
1.22
1.78
4.2
3.9
%
0.9
0.7
0.60
56
305
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
209
1761
1.20
1.78
2.6
2.3
ug/l
5.6
7.5
1.63
183
1555
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
670
1.32
1.76
2.1
1.4
g/l
10.2
10.5
0.15
69
567
(3006184) Hemoglobin [Mass/volume] in Capillary blood
56
396
1.42
1.76
2.4
2.2
g/l
131.6
132.8
0.13
37
298
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
41
2.44
1.75
1.0
1.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
17
88
1.94
1.74
2.5
2.3
%
16.7
13.1
—
9
41
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
16
81
1.98
1.74
2.6
2.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
29
178
1.64
1.73
1.2
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
433
3878
1.14
1.72
1.5
1.3
g/l
2.3
2.4
0.35
256
2302
(21494434) Karyotype in Bone marrow
24
140
1.72
1.72
1.1
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
19
103
1.85
1.71
1.1
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
37
242
1.54
1.70
1.3
1.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
48
2.30
1.70
1.5
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
48
2.30
1.70
1.5
2.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
27
164
1.65
1.68
1.7
1.5
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
12
55
2.19
1.67
1.2
1.1
%
79.3
91.2
—
6
26
(3000093) Morphology [Interpretation] in Blood Narrative
28
172
1.64
1.67
1.1
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
19
3.16
1.66
1.0
1.1
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
17
90
1.90
1.65
2.5
2.3
%
79.5
74.0
0.98
17
85
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
20
112
1.79
1.64
1.5
1.4
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
20
112
1.79
1.64
1.5
2.0
—
11.0
—
0
7
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
399
3566
1.14
1.64
1.3
1.3
iu/ml
37.5
33.8
0.19
116
1100
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
301
2642
1.16
1.60
1.6
1.6
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
8
32
2.50
1.59
1.0
1.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
280
2445
1.16
1.59
2.1
2.4
ug/g
140.8
133.4
0.11
216
1915
(3014051) Protein [Presence] in Urine by Test strip
63
465
1.36
1.57
2.0
2.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
477
4324
1.13
1.57
4.9
4.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
96
1212
0.78
1.57
1.5
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
92
719
1.29
1.56
2.1
1.4
g/l
7.1
7.4
0.94
66
534
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
92
719
1.29
1.56
2.1
1.4
g/l
3.6
3.9
1.19
64
508
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
92
719
1.29
1.56
2.1
1.4
—
—
—
0
0
(4034850)
89
693
1.29
1.55
9.4
9.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
155
1288
1.22
1.55
3.2
2.9
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
8
33
2.43
1.53
1.4
1.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
25
153
1.64
1.53
1.1
1.0
ng/l
563.1
704.2
1.40
15
98
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
25
153
1.64
1.53
1.1
1.0
ng/l
312.7
342.4
0.17
13
100
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
72
546
1.33
1.52
1.3
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
15
79
1.90
1.49
3.1
2.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
9
37
2.44
1.48
1.3
1.4
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
10
45
2.23
1.46
1.0
1.2
umol/24h
0.7
0.7
—
5
26
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
25
156
1.61
1.43
1.1
1.0
ng/l
44.1
49.7
0.27
13
98
(3000570) Elastase.pancreatic [Mass/mass] in Stool
67
508
1.33
1.43
1.4
1.4
ug/g
286.6
302.1
0.29
42
292
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
26
164
1.59
1.43
1.2
1.2
u/l
97.1
57.5
0.61
15
113
(4306422)
42
295
1.43
1.42
1.2
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
21
338
0.62
1.40
1.4
1.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
75
581
1.30
1.39
1.7
1.6
g/l
0.2
0.2
0.67
70
549
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
11
53
2.08
1.38
1.3
1.2
%
77.8
90.4
—
6
25
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
27
174
1.56
1.37
1.1
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
9
41
2.20
1.37
1.6
2.1
umol/l
23.9
18.5
—
9
41
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
57
755
0.75
1.37
1.4
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
365
3286
1.13
1.36
1.9
1.8
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
17
2.94
1.36
1.0
3.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
150
1773
0.84
1.34
1.8
1.7
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
25
159
1.58
1.34
1.3
1.4
promille
1.5
1.2
0.30
18
122
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
78
611
1.29
1.34
1.6
1.6
iu/ml
0.1
0.2
0.60
17
110
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
74
576
1.29
1.33
1.3
1.2
u/ml
17.9
42.7
—
7
32
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
12
61
1.97
1.32
2.3
2.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
43
308
1.40
1.32
1.6
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
17
98
1.74
1.31
6.0
3.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1903
18582
1.10
1.30
18.8
13.1
%
39.7
40.0
0.84
1368
13351
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
6
24
2.50
1.30
1.5
2.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
21
331
0.63
1.30
1.4
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
45
326
1.39
1.30
1.6
1.2
u/l
31.3
19.5
0.66
35
282
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
43
2.10
1.30
1.7
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
21
129
1.63
1.30
1.5
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
21
129
1.63
1.30
1.5
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
21
129
1.63
1.30
1.5
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
8
34
2.36
1.29
1.0
1.0
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
8
34
2.36
1.29
1.0
1.4
nmol/l
4.8
282148.2
—
8
28
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
34
2.36
1.29
1.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
21
328
0.64
1.26
1.4
1.4
—
—
—
0
0
(4211845)
18
107
1.69
1.25
6.2
3.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
19
115
1.66
1.24
1.6
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
472
4338
1.11
1.23
1.7
1.7
pmol/l
17571501.1
36454999.3
0.47
387
3599
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
19
2.63
1.21
2.0
2.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
8
37
2.17
1.21
1.0
1.4
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
16
93
1.73
1.21
1.9
1.6
ug/l
13.6
8.1
0.43
16
74
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
14
78
1.80
1.21
1.2
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
14
78
1.80
1.21
1.2
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
48
357
1.35
1.20
2.6
2.4
%
16.4
16.7
0.21
28
186
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
15
86
1.75
1.19
1.0
1.1
miu/ml
1159.8
1583.0
0.65
15
86
(3014271) Vancomycin [Susceptibility]
16
94
1.71
1.17
4.6
2.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
41
299
1.38
1.16
1.2
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
69
544
1.28
1.16
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
118
988
1.20
1.15
3.3
3.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
20
2.50
1.15
2.0
2.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
167
1443
1.17
1.14
4.2
3.9
%
0.1
0.1
0.44
50
282
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
30
208
1.45
1.13
1.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
11
58
1.90
1.12
1.4
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
51
1.96
1.11
1.2
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
10
51
1.96
1.11
1.8
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
67
530
1.27
1.11
2.5
2.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
121
1021
1.19
1.10
1.2
1.4
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
7
31
2.26
1.10
1.1
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
68
540
1.27
1.09
1.4
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1926
18867
1.09
1.09
5.9
5.8
mmol/mol
38.8
39.9
6.43
1778
17514
(3025549) Creatine [Moles/time] in 24 hour Urine
5
21
2.38
1.09
2.0
1.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
32
2.19
1.08
1.3
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
492
4566
1.10
1.07
1.3
1.3
u/ml
1.8
1.6
0.09
134
1202
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
74
1.76
1.06
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
49
374
1.32
1.06
1.1
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
33
2.12
1.05
2.4
2.7
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
22
2.28
1.03
1.0
1.7
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
22
2.28
1.03
2.0
1.7
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
16
98
1.64
1.03
1.9
1.8
u/field
1.1
3.9
—
9
78
(4281824)
17
106
1.61
1.02
1.3
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
63
787
0.80
1.02
1.6
1.7
mg/l
5.1
3.9
0.24
45
532
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
24
163
1.48
1.01
1.1
1.3
mmol/l
11.8
12.0
—
8
49
(44806118)
27
188
1.44
1.01
1.9
1.4
—
—
—
0
0
(44790048)
27
188
1.44
1.01
1.9
1.4
—
—
—
0
0
(44790047)
27
188
1.44
1.01
1.9
1.4
—
—
—
0
0
(44790049)
27
188
1.44
1.01
1.9
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
29
205
1.42
1.01
2.3
2.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
48
369
1.31
1.00
9.4
4.2
mmol/l
3.5
2.6
1.20
37
237
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
37
274
1.36
0.99
1.5
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
56
441
1.28
0.98
1.3
1.2
—
10.9
—
0
5
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
387
3568
1.10
0.97
1.6
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
159
1390
1.15
0.97
3.8
3.7
%
0.6
0.5
0.47
40
228
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
54
1.86
0.96
1.2
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
50
1.80
0.96
1.3
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
50
1.80
0.96
1.3
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
50
1.80
0.96
1.3
1.2
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
20
133
1.51
0.94
1.6
1.7
—
1.8
—
0
11
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
110
937
1.18
0.93
2.2
1.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
78
643
1.22
0.93
1.7
1.8
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
19
126
1.51
0.91
4.7
3.2
mu/l
14.0
31.1
1.77
19
120
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
31
227
1.37
0.90
1.7
2.4
mg/l
31.0
22.6
—
9
56
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
42
323
1.31
0.90
1.6
1.4
u/ml
100.2
106.6
—
10
58
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
30
405
0.74
0.89
1.3
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
28
202
1.39
0.89
1.5
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
20
135
1.49
0.89
1.4
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
30
404
0.74
0.88
1.3
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
52
413
1.26
0.88
1.7
1.7
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
35
263
1.34
0.88
2.1
1.9
mmol/l
1.8
1.7
0.20
35
256
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
30
403
0.74
0.87
1.3
1.4
—
—
—
0
0
(4062490)
26
186
1.40
0.87
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
30
402
0.74
0.86
1.3
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
22
153
1.44
0.85
1.2
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
8
46
1.74
0.82
2.3
2.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
214
1.36
0.82
1.4
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
32
240
1.34
0.82
1.5
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
36
276
1.31
0.80
1.2
1.1
u/ml
7.0
2.5
0.56
16
126
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
48
383
1.26
0.80
1.4
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
40
312
1.29
0.79
1.1
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
24
173
1.39
0.78
4.8
4.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
29
217
1.34
0.77
2.6
2.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
20
140
1.43
0.77
3.2
2.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
12
186
0.64
0.76
1.2
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
21
149
1.41
0.75
1.8
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
12
75
1.60
0.75
1.3
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
5
24
2.09
0.74
1.8
1.5
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
5
24
2.09
0.74
1.0
1.1
mmol/l
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
10
60
1.67
0.72
1.4
1.1
g/l
42.1
37.9
—
5
31
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
12
76
1.58
0.71
2.0
3.4
umol/l
389.8
189.7
—
5
47
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
35
444
0.79
0.71
1.4
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
16
109
1.47
0.71
1.8
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
161
1446
1.12
0.70
4.6
2.8
mmol/l
1.2
1.2
0.14
151
1203
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
26
1.92
0.70
1.6
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
26
1.92
0.70
1.0
1.2
umol/24h
2.0
1.8
—
5
26
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
26
1.92
0.70
1.6
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
26
1.92
0.70
1.6
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
18
126
1.43
0.70
1.2
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
15
101
1.49
0.70
1.3
1.7
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
41
1.71
0.70
1.4
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
9
58
1.55
0.69
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
9
58
1.55
0.69
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
9
58
1.55
0.69
1.2
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
9
58
1.55
0.69
1.2
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
90
1038
0.86
0.69
1.7
1.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
64
537
1.20
0.69
1.3
1.2
u/ml
2.1
7.6
—
8
91
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
44
355
1.24
0.69
1.6
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
33
257
1.29
0.68
1.5
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
76
649
1.18
0.68
1.7
1.9
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
63
529
1.20
0.68
1.3
1.2
u/ml
62.8
2.7
—
5
50
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
47
383
1.23
0.68
1.4
1.3
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
93
808
1.16
0.67
1.2
1.2
u/ml
0.3
1.1
1.54
12
73
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
131
1166
1.13
0.67
2.3
1.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
168
1856
0.90
0.67
1.4
1.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
23
170
1.36
0.67
1.4
1.5
g/l
33.4
28.3
1.24
23
150
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
120
0.58
0.67
1.0
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
34
267
1.28
0.67
1.2
1.3
mmol/l
6.6
7.6
1.87
22
190
(3025159) Blasts/100 leukocytes in Blood
153
1377
1.12
0.66
4.2
4.0
%
0.0
0.4
0.51
43
250
(3023419) Bacteria identified in Sputum by Culture
32
250
1.28
0.65
4.0
2.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
363
3405
1.08
0.65
1.3
1.2
u/ml
15.5
11.8
0.15
145
1321
(3021788) Differential panel - Synovial fluid
44
358
1.23
0.65
1.4
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
166
0.66
0.64
1.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
14
95
1.48
0.64
1.1
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
8
129
0.62
0.63
1.3
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
40
323
1.24
0.63
4.2
2.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
17
121
1.41
0.62
1.1
1.2
ratio
1.1
1.1
—
7
49
(3047189) Immunofixation for 24 hour Urine
8
49
1.63
0.62
1.1
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
51
1.57
0.60
2.5
2.6
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
26
201
1.30
0.59
3.6
6.1
mmol/l
6.7
7.3
0.42
20
162
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
148
1341
1.11
0.58
1.2
1.2
iu/ml
140.5
151.4
0.12
57
515
(3000475) Leukocytes [#/volume] in Synovial fluid
56
474
1.19
0.58
1.4
1.6
e6/l
9088.9
12670.5
0.49
44
350
(3051651) Icteric interference index of Serum or Plasma
13
89
1.46
0.58
1.6
4.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
17
123
1.38
0.57
1.1
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
15
106
1.42
0.57
1.1
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
54
1.48
0.57
1.1
1.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
8
54
1.48
0.57
1.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
8
54
1.48
0.57
1.1
1.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
29
229
1.27
0.57
1.6
1.7
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
50
420
1.19
0.56
1.2
1.2
u/ml
31.7
45.5
—
7
40
(3024263) Appearance of Synovial fluid
16
115
1.39
0.56
2.3
1.6
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
37
1.62
0.55
1.3
1.6
—
—
—
0
0
(3034426) Prothrombin time (PT)
10
65
1.54
0.55
1.4
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
90
1.45
0.55
1.5
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
29
361
0.80
0.54
1.3
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
61
1.48
0.53
1.3
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
61
1.48
0.53
1.3
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
180
1657
1.09
0.53
1.2
1.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
14
193
0.72
0.53
1.1
1.3
nmol/l
1.6
1.4
0.25
14
173
(3006576) Bicarbonate [Moles/volume] in Blood
9
62
1.45
0.53
10.6
6.8
mmol/l
26.7
25.4
—
9
56
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
10
66
1.52
0.52
1.3
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
10
66
1.52
0.52
1.3
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
10
66
1.52
0.52
1.3
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
10
66
1.52
0.52
1.3
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
63
726
0.86
0.52
1.4
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
541
5186
1.06
0.52
4.0
3.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
25
315
0.79
0.52
1.3
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
83
1.45
0.51
1.2
1.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
24
188
1.28
0.51
1.7
1.4
%
25.1
30.3
0.45
18
116
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
18
236
0.76
0.50
1.5
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
46
390
1.18
0.49
4.1
2.8
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
27
334
0.81
0.49
1.1
1.1
u/ml
0.3
2.6
—
7
84
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
45
1.56
0.49
1.4
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
20
256
0.78
0.48
1.1
1.1
u/ml
2.4
5.0
0.79
12
109
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
12
85
1.41
0.47
1.2
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
44
515
0.85
0.46
2.4
2.4
ug/min
51.5
115.8
1.67
31
321
(3003888) Timothy IgE Ab [Units/volume] in Serum
30
364
0.82
0.46
1.1
1.1
u/ml
2.7
5.5
1.35
16
203
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
49
1.43
0.46
1.0
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
54
468
1.16
0.45
4.5
4.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
15
112
1.34
0.44
1.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
22
273
0.80
0.42
1.4
1.5
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
32
1.56
0.42
2.2
1.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
32
1.56
0.42
1.6
3.4
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
17
131
1.30
0.42
1.2
1.4
u/l
4.8
7.1
1.91
12
116
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
26
316
0.82
0.41
1.4
1.7
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
33
1.52
0.41
4.6
2.9
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.3
—
9.9
—
0
15
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
64
567
1.13
0.41
1.3
1.3
miu/ml
154.9
221.6
0.72
22
256
(3016031) Almond IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
1.9
—
0
8
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
79
1.39
0.40
1.6
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
79
1.39
0.40
1.6
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
57
502
1.14
0.40
1.9
1.9
iu/l
3.2
4.9
1.18
19
174
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
19
150
1.27
0.40
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
19
150
1.27
0.40
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
19
150
1.27
0.40
1.1
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
12
160
0.75
0.39
1.6
1.5
g/l
0.9
1.0
0.06
12
160
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
320
3052
1.06
0.39
1.3
1.4
—
—
—
0
0
(4094501)
63
560
1.13
0.39
1.2
1.1
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
0
19
0.00
0.39
0.0
1.4
—
1986.5
—
0
11
(3045788) Cell count panel - Pleural fluid
17
133
1.28
0.38
1.4
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
42
484
0.87
0.38
1.4
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
19
152
1.25
0.37
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
19
152
1.25
0.37
1.1
1.1
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
8
116
0.69
0.37
1.6
1.4
umol/l
11.4
21.8
—
8
108
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
255
2423
1.06
0.36
2.0
1.7
%
1.5
1.5
0.29
230
2134
(3024891) Influenza virus A+B Ag [Presence] in Specimen
58
516
1.13
0.36
1.1
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
42
1.43
0.35
1.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
19
153
1.24
0.35
1.1
1.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
14
108
1.30
0.35
1.0
1.1
u/ml
—
12.4
—
0
11
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
10
134
0.75
0.35
1.3
1.4
—
1.5
—
0
8
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
6
44
1.36
0.34
1.2
1.1
mmol/l
22.0
20.0
—
6
37
(3014133) Dog dander IgE Ab [Units/volume] in Serum
23
276
0.83
0.34
1.1
1.1
u/ml
1.2
2.8
0.98
12
114
(3030905) Polymorphonuclear cells [#/volume] in Blood
40
349
1.15
0.33
4.5
3.2
e9/l
4.4
4.1
0.16
40
349
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
45
1.33
0.33
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
14
109
1.29
0.33
1.6
1.5
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
14
109
1.29
0.33
1.2
1.6
mmol/l
6.2
7.9
—
5
66
(4133840)
6
46
1.31
0.33
1.3
1.2
—
—
—
0
0
(44813793)
17
137
1.24
0.32
1.1
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2080
20661
1.04
0.31
5.1
5.0
mmol/l
2.8
2.8
0.19
1921
19117
(3013139) Helicobacter pylori Ag [Presence] in Stool
142
1334
1.07
0.30
1.3
1.2
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
7
55
1.27
0.30
1.3
2.8
—
5054.9
—
0
8
(3015183) Erythrocyte sedimentation rate
13
102
1.28
0.30
1.0
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
12
93
1.29
0.30
2.3
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
57
515
1.11
0.29
1.1
1.2
titre
74.3
96.7
—
7
40
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
19
157
1.21
0.29
1.9
2.2
u/field
1.1
2.0
—
8
70
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1963
19486
1.04
0.29
4.1
4.0
mmol/l
1.3
1.3
0.73
1791
17891
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
20
238
0.84
0.28
1.1
1.1
u/ml
0.1
0.4
—
5
67
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
41
364
1.13
0.28
1.4
1.3
u/ml
210.8
250.5
0.77
31
217
(3051387) C reactive protein [Mass/volume] in Capillary blood
37
418
0.88
0.28
3.6
3.6
mg/l
17.6
27.1
1.82
16
274
(3027008) Opiates [Presence] in Urine
79
729
1.09
0.28
2.8
1.9
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
31
354
0.87
0.27
1.1
1.1
u/ml
0.4
1.1
0.83
14
165
(3016879) Cocaine [Presence] in Urine
74
681
1.09
0.27
2.9
1.9
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
118
0.76
0.27
1.2
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
40
356
1.13
0.27
5.0
3.4
%
57.6
57.2
0.06
40
356
(3013166) Neutrophils/100 leukocytes in Synovial fluid
8
65
1.23
0.27
1.3
1.2
%
62.3
55.3
—
8
56
(3048929) Epstein Barr virus Ab [Presence] in Serum
67
615
1.09
0.26
1.3
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
62
567
1.10
0.26
1.4
1.3
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
40
447
0.89
0.26
2.6
1.8
nmol/l
0.9
0.8
0.28
34
364
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2030
20175
1.03
0.25
4.6
4.4
mmol/l
1.5
1.5
1.16
1877
18661
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
546
5593
0.97
0.25
1.7
1.6
mmol/l
1.4
1.4
0.31
474
4702
(3047007) Chlamydophila sp Ab [Presence] in Serum
34
301
1.13
0.25
1.3
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
9
73
1.23
0.25
1.3
1.3
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
19
160
1.19
0.25
1.4
1.5
pmol/l
43.1
240.6
—
9
50
(3028300) Cannabinoids [Presence] in Urine
79
733
1.08
0.25
2.8
1.8
—
—
—
0
0
(4146454)
27
235
1.15
0.25
3.3
2.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
74
1.22
0.25
5.0
4.5
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
32
283
1.13
0.24
2.1
2.0
—
3.3
—
0
6
(4010399)
150
1426
1.06
0.24
1.5
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
158
0.82
0.23
1.2
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
44
399
1.10
0.23
1.4
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
39
1.28
0.23
1.2
1.9
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
94
0.74
0.22
1.1
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
18
153
1.18
0.22
4.7
2.1
%
10.9
11.3
0.21
18
153
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
29
257
1.13
0.22
1.0
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
125
1315
0.95
0.21
1.3
1.3
u/ml
143.5
247.9
1.96
114
1211
(3013762) Body weight Measured
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2042
20316
1.03
0.21
4.6
4.5
mmol/l
4.7
4.7
0.53
1897
18894
(3000492) Spirometry study
197
1897
1.04
0.20
1.5
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
16
136
1.18
0.20
1.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
51
1.18
0.19
1.5
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
77
724
1.07
0.19
2.9
1.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
76
716
1.06
0.18
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
112
1068
1.05
0.18
1.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
12
100
1.20
0.18
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
16
138
1.16
0.17
1.3
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
68
0.73
0.17
1.6
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
26
288
0.90
0.16
1.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
8
71
1.13
0.16
1.1
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
76
720
1.06
0.16
2.9
1.9
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
72
1.11
0.16
1.0
1.1
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
11
130
0.85
0.16
1.3
1.4
mmol/l
4.7
7.1
1.71
11
117
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
219
2128
1.03
0.16
2.2
2.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
77
0.78
0.15
3.3
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
60
565
1.06
0.15
3.3
1.9
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
87
0.80
0.14
1.3
1.9
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
37
399
0.93
0.14
1.1
1.1
u/ml
0.9
2.1
0.70
14
178
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
7
88
0.79
0.14
1.1
1.8
u/l
191.9
197.8
—
7
88
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
172
1670
1.03
0.13
2.9
3.1
ng/l
135.4
197.3
1.91
152
1525
(3005570) Glucose [Moles/volume] in Urine
24
218
1.10
0.13
1.5
2.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
634
6420
0.98
0.13
3.7
4.0
mg/mmol
10.0
8.6
0.12
391
4070
(3004451) EKG impression Narrative
11
94
1.17
0.13
1.2
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
153
1575
0.97
0.12
5.2
3.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
41
386
1.06
0.11
1.4
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
185
1895
0.97
0.11
1.4
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
33
308
1.07
0.11
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
31
332
0.93
0.11
1.4
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
52
495
1.05
0.10
4.7
2.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
20
183
1.09
0.10
3.2
2.9
mg/l
34.9
24.4
0.22
13
134
(3018133) Calcium [Moles/volume] in Urine
5
45
1.11
0.09
1.8
2.3
mmol/l
3.1
3.2
—
5
39
(3006653) Thiamine [Moles/volume] in Blood
12
106
1.13
0.09
1.2
1.3
nmol/l
132.6
142.3
0.48
12
106
(3004775) Volume in Urine collected for unspecified duration
18
164
1.10
0.09
2.0
2.3
ml
687.8
635.1
0.38
12
110
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
61
585
1.04
0.09
1.1
1.1
u/ml
4.8
5.5
—
9
72
(3019832) Treponema pallidum Ab [Presence] in Serum
173
1693
1.02
0.09
1.6
1.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
23
213
1.08
0.09
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
22
237
0.93
0.09
1.3
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
18
165
1.09
0.08
1.4
1.3
u/ml
0.4
1.2
0.58
12
75
(3042733) HLA Ab [Presence] in Serum
6
56
1.07
0.08
8.8
4.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
56
1.07
0.08
1.2
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
6
57
1.05
0.08
2.8
1.6
—
—
—
0
0
(3024471) HLA-A [Type]
6
57
1.05
0.08
1.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
113
0.88
0.08
1.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
62
0.81
0.08
1.8
2.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
11
98
1.12
0.07
6.1
12.8
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
6
73
0.82
0.07
3.0
1.7
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
75
1.07
0.07
1.0
1.0
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
8
76
1.05
0.07
1.0
1.3
u/l
20.3
9.9
—
8
66
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
78
1.03
0.07
1.1
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
34
324
1.05
0.07
3.2
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
8
91
0.88
0.06
1.1
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
95
0.84
0.06
1.0
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
225
2280
0.99
0.06
1.6
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
195
1922
1.02
0.06
2.1
2.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
26
248
1.05
0.05
1.7
1.5
%
65.9
62.6
0.19
18
152
(3009508) Creatinine [Moles/volume] in Urine
658
6546
1.01
0.05
3.3
3.2
mmol/l
7.7
7.6
0.27
562
5546
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
119
0.92
0.04
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
31
321
0.97
0.03
1.2
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
38
370
1.03
0.03
2.1
1.6
—
—
—
0
0
(3016750) Collection duration of Urine
13
122
1.07
0.02
1.4
2.0
min
482.1
500.1
—
8
91
(3003740) Influenza virus B Ag [Presence] in Specimen
31
319
0.97
0.02
1.2
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
29
298
0.97
0.02
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
33
338
0.98
0.01
1.7
1.6
—
—
—
0
0
(1002224) Polysomnography panel
84
831
1.01
0.01
1.1
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
609
6101
1.00
0.01
3.1
3.3
mg/l
330.4
221.0
0.27
383
3849
(3017569) Oxygen content in Arterial blood
10
95
1.05
0.00
1.5
1.8
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
115
0.96
0.00
1.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
10
101
0.99
0.00
2.2
1.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
18
179
1.01
0.00
1.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
32
325
0.98
0.00
1.6
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
75
749
1.00
0.00
1.6
1.6
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
114
0.96
0.00
1.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
63
628
1.00
0.00
1.3
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
36
357
1.01
0.00
2.9
3.3
nmol/l
0.7
0.8
1.41
21
275
(3045683) HLA typing for celiac disease panel - Blood or Tissue
13
127
1.02
0.00
1.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
14
137
1.02
0.00
1.3
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
17
167
1.02
0.00
1.2
1.1
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
2.1
—
4.1
—
0
8
(3029075) Extractable nuclear Ab panel - Serum
5
52
0.96
0.00
1.0
1.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
8
0.00
0.00
0.0
5.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
87
0.92
0.00
1.3
1.1
iu/ml
175.9
207.8
—
8
87
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
52
0.96
0.00
1.4
1.3
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
5
52
0.96
0.00
4.4
2.5
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
2.2
—
0
5
(3013862) HLA-DP [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
123.1
—
0
6
(3040893) Potassium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
2.2
—
4.5
—
0
6
(4198724)
8
80
1.00
0.00
1.6
1.9
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
9
0.00
0.00
0.0
5.1
—
372.9
—
0
9
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
29.7
—
0
6
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
25.6
—
0
5
(3010937) Rubella virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
2.3
—
0
7
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
6
69
0.87
0.00
1.3
1.1
%
114.8
110.3
—
6
58
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
9
91
0.99
0.00
1.3
1.4
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
7
69
1.01
0.00
1.0
1.1
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
7.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_BRAIN_CNS_EXALLC – Benign neoplasm of brain and other parts of central nervous system
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).